Acute graft‐versus‐host disease (GVHD) is a leading cause of non‐relapse mortality
following allogeneic haematopoietic cell transplantation. Attempts to improve treatment …

Hematopoietic stem cell transplantation (HSCT) provides a unique environment in which to
evaluate the role of immunogenetics of both the donor and the recipient to success of the …

To validate current donor selection strategies based on previous international studies, we
retrospectively analyzed 2646 transplantations performed for hematologic malignancies in …

Biology-based markers to confirm or aid in the diagnosis or prognosis of chronic graft-versus-
host disease (GVHD) after allogeneic hematopoietic cell transplantation or monitor its …

OBJECTIVE: The purpose of this study was to examine the relationship between preterm
birth and 22 single nucleotide polymorphisms in genes that encode cytokines and mediators …

Candidate genetic associations with acute GVHD (aGVHD) were evaluated with the use of
genotyped and imputed single-nucleotide polymorphism data from genome-wide scans of …

Allogeneic stem cell transplantation is associated with a high risk of treatment-related
mortality mainly caused by infections and graft-versus-host disease (GVHD). GVHD is …

The current study attempted to evaluate the association between the IL-10 promoter gene
single nucleotide polymorphism (SNP) and invasive pulmonary aspergillosis (IPA) after …

Biologic markers of chronic GVHD may provide insight into the pathogenesis of the
syndrome, identify molecular targets for novel interventions, and facilitate advances in …

Most fungal infections in humans occur in the setting of iatrogenic immunosuppression or
HIV infection. In the absence of these factors, fungi cause mild, self-limited infections that …